We are live on
!
Find out more
Lifecore Biomedical
LFCR
LFCR
103 hedge funds and large institutions have $226M invested in Lifecore Biomedical in 2025 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 26 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
284% more call options, than puts
Call options by funds: $879K | Put options by funds: $229K
31% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 26
29% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 14
13% more capital invested
Capital invested by funds: $199M → $226M (+$26.6M)
3% more funds holding
Funds holding: 100 → 103 (+3)
1.16% more ownership
Funds ownership: 65.01% → 66.17% (+1.2%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
Holders
103
Holders Change
+3
Holders Change %
+3%
% of All Funds
1.25%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
18
Increased
34
Reduced
26
Closed
14
Calls
$879K
Puts
$229K
Net Calls
+$650K
Net Calls Change
+$906K
Top Buyers
| 1 |
Millennium Management
New York
|
+$862K |
| 2 |
DC
Diametric Capital
Boston,
Massachusetts
|
+$679K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$612K |
| 4 |
BlackRock
New York
|
+$492K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$454K |
Top Sellers
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$900K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$360K |
| 3 |
Squarepoint
New York
|
-$299K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$282K |
| 5 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
-$278K |
